Dynamic contrast‐enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
Authors:
- 20 May 2014
- journal article
- research article
- Published by Wiley in NMR in Biomedicine
- Vol. 27 (8) , 887-896
Abstract
The aim of this study was to investigate the potential of texture analysis, applied to dynamic contrast‐enhanced MRI (DCE‐MRI), to predict the clinical and pathological response to neoadjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC) before NAC is started. Fifty‐eight patients with LABC were classified on the basis of their clinical response according to the Response Evaluation Criteria in Solid Tumors (RECIST) guidelines after four cycles of NAC, and according to their pathological response after surgery. T1‐weighted DCE‐MRI with a temporal resolution of 1 min was acquired on a 3‐T Siemens Trio scanner using a dedicated four‐channel breast coil before the onset of treatment. Each lesion was segmented semi‐automatically using the 2‐min post‐contrast subtracted image. Sixteen texture features were obtained at each non‐subtracted post‐contrast time point using a gray level co‐occurrence matrix. Appropriate statistical analyses were performed and false discovery rate‐based q values were reported to correct for multiple comparisons. Statistically significant results were found at 1–3 min post‐contrast for various texture features for the prediction of both the clinical and pathological response. In particular, eight texture features were found to be statistically significant at 2 min post‐contrast, the most significant feature yielding an area under the curve (AUC) of 0.77 for response prediction for stable disease versus complete responders after four cycles of NAC. In addition, four texture features were found to be significant at the same time point, with an AUC of 0.69 for response prediction using the most significant feature for classification based on the pathological response. Our results suggest that texture analysis could provide clinicians with additional information to increase the accuracy of prediction of an individual response before NAC is started. Copyright © 2014 John Wiley & Sons, Ltd.Keywords
Funding Information
- Central Norway Regional Health Authority (RHA)
- Liaison Committee between the RHA and the Norwegian University of Science and Technology (NTNU)
- NTNU Strategic Area of Medical Technology
This publication has 36 references indexed in Scilit:
- DCE‐MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: Pilot study findingsMagnetic Resonance in Medicine, 2013
- Monitoring neoadjuvant chemotherapy in breast cancer patients: Improved MR assessment at 3 T?Journal of Magnetic Resonance Imaging, 2011
- Neoadjuvant therapy for breast cancerJournal of Surgical Oncology, 2010
- Dynamic contrast‐enhanced MRI in the diagnosis and management of breast cancerNMR in Biomedicine, 2008
- Locally Advanced and Inflammatory Breast CancerJournal of Clinical Oncology, 2008
- Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant ChemotherapyJournal of Clinical Oncology, 2007
- MR Imaging for Surveillance of Women at High Familial Risk for Breast CancerMagnetic Resonance Imaging Clinics of North America, 2006
- Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary ChemotherapyJournal of Clinical Oncology, 2005
- Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesionsCancer, 2005
- Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic PredispositionNew England Journal of Medicine, 2004